Table 3.
PSQI, ESS, and CPAP use before and after administration of antiallergic agents
| Variable | Baseline | Post-treatment | p-value |
|---|---|---|---|
| PSQI score | 5.6 ± 3.2 [5.5] | 3.8 ± 3.1 [3.0] | 0.046* |
| ESS score | 6.9 ± 4.0 | 7.1 ± 4.6 | 0.565 |
| Nasal symptoms score | |||
| Sneezing score | 1.5 ± 0.9 [1.0] | 1.1 ± 0.7 [1.0] | 0.020 |
| Rhinorrhea score | 2.0 ± 1.0 [2.0] | 1.4 ± 1.0 [1.0] | 0.007 |
| Nasal blockage score | 1.5 ± 0.8 [1.5] | 0.7 ± 0.7 [0.7] | < 0.001 |
| QOL (troubles of daily life) score | 1.0 ± 0.7 [1.0] | 0.4 ± 0.6 [0.4] | 0.001 |
| Downloading data from CPAP | |||
| Percent days with CPAP usage (%) | 88.4 ± 18.4 | 90.9 ± 15.5 | 0.090 |
| Percent of days with CPAP usage > 4 h (%) | 75.3 ± 29.4 | 83.3 ± 24.8 | 0.022* |
| Average usage (min) | 367 ± 99.5 [370] | 370.7 ± 101.5 [378] | 0.326 |
| Average AHI on CPAP (events/h) | 3.0 ± 3.6 [2.1] | 3.3 ± 3.6 [2.3] | 0.106 |
| Average CPAP < 90% pressure in 90% of usage time (cmH2O) | 8.4 ± 2.0 [7.8] | 8.3 ± 1.9 [8.1] | 0.513 |
Values are expressed as mean ± SD or median (interquartile range). CPAP continuous positive airway pressure, AHI apnea hypopnea index, ESS Epworth Sleepiness Scale, PSQI Pittsburgh Sleep Quality Index
*Significant values